Driving change in Cell & Gene Therapies: Key learnings from the SITC Virtual Summit
Chris Learn, Head of Cell and Gene COE at Parexel discusses his participation at the recent Clinical Research Virtual Summit hosted by the Society for Immunotherapy of Cancer, and the implications for clinical research.
Related Insights
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Blog
SITC Crisis in Clinical Research Virtual Summit – Collaborating to Drive Change
Aug 24, 2022
Video
Oncology experts roundtable: Practical insights on FDA draft guidance discussing OS data in cancer trials
Oct 24, 2025
Article
Five strategies for meeting the requirements of Project Optimus and improving the chances of approval
Nov 10, 2022
Podcast
Preparing for a Cell and Gene Future | Episode 1: Looking Back at 2023 Achievements
Jan 10, 2024
Blog
New Oncology head brings biotech industry and academic research experience
Oct 2, 2023
Blog
Studying rare cancer patient populations using integrated genomic and real-world data
Aug 30, 2023
Blog
A hybrid model supports globally diverse site participation for a retrospective cancer study
Jul 24, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Playbook
Mitigating risk, protecting potential: Practical strategies that position cell and gene therapy development for success
Mar 28, 2023
Blog
The New Frontier of Innovative Therapies: Navigating What's Next
Jan 12, 2023
Related Insights
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Blog
SITC Crisis in Clinical Research Virtual Summit – Collaborating to Drive Change
Aug 24, 2022
Video
Oncology experts roundtable: Practical insights on FDA draft guidance discussing OS data in cancer trials
Oct 24, 2025
Article
Five strategies for meeting the requirements of Project Optimus and improving the chances of approval
Nov 10, 2022
Podcast
Preparing for a Cell and Gene Future | Episode 1: Looking Back at 2023 Achievements
Jan 10, 2024
Blog
New Oncology head brings biotech industry and academic research experience
Oct 2, 2023
Blog
Studying rare cancer patient populations using integrated genomic and real-world data
Aug 30, 2023
Blog
A hybrid model supports globally diverse site participation for a retrospective cancer study
Jul 24, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Playbook
Mitigating risk, protecting potential: Practical strategies that position cell and gene therapy development for success
Mar 28, 2023
Blog
The New Frontier of Innovative Therapies: Navigating What's Next
Jan 12, 2023